store at low temperature
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
PSMA-ALB-56 is a PSMA-targeting radioactive ligand with antitumor activity designed by binding glutamic urea PSMA binding entities, DOTA chelating agents, and albumin binators based on 4-(p-iodophenyl)- fragment or p(tolyl)- fragment.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
5 mg | Inquiry | $ 1,328.00 |
Description | PSMA-ALB-56 is a PSMA-targeting radioactive ligand with antitumor activity designed by binding glutamic urea PSMA binding entities, DOTA chelating agents, and albumin binators based on 4-(p-iodophenyl)- fragment or p(tolyl)- fragment. |
In vivo | PSMA-ALB-56 demonstrates rapid accumulation in tumor tissues and enhanced clearance from the bloodstream and non-target tissues, leading to superior tumor-to-background contrast within just 4 hours post-injection. Additionally, PSMA-ALB-56 is associated with an increase in median survival in mice [1]. |
Molecular Weight | 1330.52 |
Formula | C66H95N11O18 |
CAS No. | 2306049-48-7 |
store at low temperature
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
PSMA-ALB-56 2306049-48-7 PSMA ALB 56 PSMAALB56 inhibitor inhibit